Edesa Biotech, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
EDSA on Nasdaq
Location
Markham
Fiscal year end
30 September
Latest financial report
13 Feb 2026

Quick Takeaways

  • EDSA - Edesa Biotech, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity -96%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-36%</span>.
  • Most recent SEC facts end date: 31 Dec 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-12-31) highlights Return On Equity -96.4%, Return On Assets -55.3%, and Operating Margin 0.0%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

3.6/100

Weak Confidence medium

Return On Equity

-96%

Metric score 0.0/100

Return On Assets

-55%

Metric score 0.0/100

Financial Health

Current Ratio
16.82x
Quick Ratio
16.51x

Strengths

No strong signals yet.

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-96%

YoY: -36%

Industry median: -43% (n=671)

View history

Return On Assets

-55%

YoY: -19%

Industry median: -48% (n=669)

View history

Operating Margin

0%

YoY:

Industry median: -128% (n=298)

View history

Current Ratio

16.82x

YoY: +1442%

Industry median: 3.39x (n=667)

View history

Quick Ratio

16.51x

YoY:

Industry median: 2.02x (n=287)

View history

NetIncomeLoss YoY

-28%

YoY:

Industry median: -0.54% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -96% -36%
Return On Assets -55% -19%
Operating Margin 0%

Financial Health

Metric Latest value YoY change
Current Ratio 16.82x +1442%
Quick Ratio 16.51x

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -28%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 8,333,823 +140%
Common Stock, Shares, Outstanding 8,333,823 +140%
Common Stock, Value, Issued $57,899,593 +22%
Weighted Average Number of Shares Outstanding, Basic 7,972,532 +138%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $3,773,647 +18%
General and Administrative Expense $4,580,613 +19%
Operating Income (Loss) $8,354,260 -18%
Nonoperating Income (Expense) $539,121 -43%
Earnings Per Share, Basic -1.07 +43%
Cash and Cash Equivalents, at Carrying Value $12,100,000 +656%
Assets, Current $12,717,487 +514%
Assets $14,710,442 +253%
Liabilities, Current $756,163 -60%
Accumulated Other Comprehensive Income (Loss), Net of Tax $171,086 +24%
Retained Earnings (Accumulated Deficit) $68,196,040 -13%
Stockholders' Equity Attributable to Parent $13,954,279 +516%
Liabilities and Equity $14,710,442 +253%
Share-based Payment Arrangement, Noncash Expense $399,862 +393%
Net Cash Provided by (Used in) Operating Activities $2,087,334 -38%
Net Cash Provided by (Used in) Financing Activities $3,355,419 +62%
Common Stock, Shares, Issued 8,333,823 +140%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,259,576 +139%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12,051,748 +671%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $7,763,068 -27%
Additional Paid in Capital $15,124,219 +6.7%
Amortization of Intangible Assets $30,000 0%
Depreciation, Depletion and Amortization $25,460 -41%
Share-based Payment Arrangement, Expense $400,000 +400%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY